Chronic nobiletin treatment enhances the amplitude or expression of clock genes in the peripheral tissues and cortex of young and older high-fat-diet-treated [8] or Alzheimer’s disease model (APP/PS1) mice [23,24]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.